Riskpilot← Back to searchSign inGet full accessBIO TECH OCEAN AS
ASActiveOrg 826580372Sandevegen 631, 5977 ÅnnelandForskning og utviklingsarbeid innen bioteknologi · NACE 72110Est. 20210 employees
Revenue 2023
NOK 0
EBITDA margin
—
-13410% vs 2022
Equity ratio
92.6%
Financial strength
Net profit 2023
NOK -53K
-13446% vs 2022
| Revenue | NOK 0 | — |
| EBITDA | NOK -53K | -13410% |
| Net profit | NOK -53K | -13446% |
| Total assets | NOK 106K | +1485% |
| Equity | NOK 98K | +1367% |
| Employees | 0 | — |
Legal name
BIO TECH OCEAN AS
Org number
826580372
Legal form
Aksjeselskap
NACE code
72110 · Forskning og utviklingsarbeid innen bioteknologi
Founded
12. februar 2021
Share capital
NOK 209 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Eierskap til og forvaltning av grønne investeringer innen akvakultur, med fokus på utvikling av marine ressurser og innovasjon innen biomarin industri, samt investering og eierskap, organisering og drift av slike selskaper.
Address
Sandevegen 631, 5977 Ånneland
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenue | 70 | 34 | 0 |
| Staff expenses | −0 | −0 | −0 |
| EBITDA | −48 | 0 | −53 |
| Depreciation & amort. | −0 | −0 | −0 |
| EBIT | −48 | 0 | −53 |
| Net financials | 0 | 0 | −0 |
| Profit before tax | −48 | 0 | −53 |
| Tax | −0 | −0 | −0 |
| Net profit | −48 | 0 | −53 |
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Total assets | 71 | 7 | 106 |
| Equity | −8 | −8 | 98 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 79 | 14 | 8 |
| Total debt | 79 | 14 | 8 |
EBITDA margin
-5297400.0%
This company
15.8%
Market median
-33527948% vs market
20212023
Equity ratio
92.6%
This company
38.2%
Market median
+142% vs market
20212023
Return on equity
-54.1%
This company
18.4%
Market median
-394% vs market
20212023
Net profit margin
-5311800.0%
This company
8.1%
Market median
-65577878% vs market
20212023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212023
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20212023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2020-12-31 – 2021-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Bio Fjord As | Company | 32.8% | 32.8% | 2024 |
Marck Invest As | Company | 32.8% | 32.8% | 2024 |
Baby Group As | Company | 32.8% | 32.8% | 2024 |
Skipavika Innovation As | Company | 20.0% | 20.0% | 2022 |
Bedriftsutvikling As | Company | 1.7% | 1.7% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Baby Group As
BIO TECH OCEAN AS Board members of BIO TECH OCEAN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Bjarne Hellandsjø | Board of Directors | 0 companies |
| Gunnar Johan Onarheim Sulen | Board of Directors | 0 companies |
| Lars Jacob Engelsen | Board of Directors | 0 companies |
| Anders Haugland | Chairman | 0 companies |
| Ragnar Eilert Brynildsen | Board of Directors | 0 companies |